In a search of the more recent literature and writings, I have been unable to find any reference to the use of hexylresorcinol (S.T.37) in the treatment for Vincent's angina. This drug, used in conjunction with sodium perborate, has seemed, in a series of thirty cases, to have an almost specific action on the condition.
I first made use of this drug one year ago, when treating a patient with the severest case of Vincent's angina that it has been my privilege to see. A history of increasing soreness of the mouth over a period of four weeks was obtained from the family physician and relatives. Local and large intravenous doses of arsphenamine had been administered, and until two days before examination the patient had been ambulatory.
When first seen, the patient was in a delirious condition, alternating with coma; exaggerated reflexes and membranous formation within the oral cavity and
BUTLER H. USE OF HEXYLRESORCINOL IN THE TREATMENT OF VINCENT'S ANGINA. Arch Otolaryngol. 1930;12(4):525. doi:10.1001/archotol.1930.03570010589012
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: